|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 09, 2012 |
Title |
Transcriptional profiles of unfractionated lymph nodes cells obtained from completely protected, non protected and unvaccinated control rhesus macaques seven days prior to, and four and fourteen days after wt SIVmac239 challenge by microarray analysis. |
Platform organism |
Homo sapiens |
Sample organism |
Macaca mulatta |
Experiment type |
Expression profiling by array
|
Summary |
Live-attenuated SIV vaccines (LAVs) remain the most efficacious of all vaccines in nonhuman primate models of HIV/AIDS, yet the basis of their robust protection remains poorly understood. Here, we demonstrate that the degree of LAV-mediated protection against intravenous (IV) wildtype (wt) SIVmac239 challenge strongly correlates with the magnitude and function of SIV-specific, effector-differentiated T cells in lymph node (LN), but not with such T cell responses in blood or with other cellular, humoral and innate immune parameters. Maintenance of protective T cell responses was associated with persistent LAV replication in LN, which occurred almost exclusively in follicular helper T cells. Thus, effective LAVs maintain lymphoid tissue-based, effector-differentiated, SIV-specific T cells that intercept and suppress early wt SIV amplification and, if present in sufficient frequencies, can completely control and perhaps clear infection -- an observation that provides rationale for development of safe, persistent vectors that can elicit and maintain such responses.
|
|
|
Overall design |
There are four protection outcome groups: unvaccinated control (C), complete protect (CP), non-protect (NP) and partial protect (PP). Respectively for these groups, there are 7, 9, 6 and 4 animals sampled seven days pre-challenge (minus7PCD); 9, 13, 5 and 5 animals sampled four days post-challenge (4PCD) and 8, 11, 5 and 3 fourteen days post-challenge (14PCD).
|
|
|
Contributor(s) |
Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, Coombes N, Mahyari E, Hagen S, Bae JY, Delos Reyes M, Swanson T, Legasse AW, Sylwester A, Hansen SG, Smith AT, Stafova P, Shoemaker R, Li Y, Oswald K, Axthelm MK, McDermott A, Ferrari G, Montefiori DC, Edlefsen PT, Piatak M, Lifson JD, Sékaly RP, Picker LJ, Wilkinson PA |
Citation(s) |
22961108 |
Submission date |
Aug 08, 2012 |
Last update date |
Mar 20, 2017 |
Contact name |
Peter A Wilkinson |
Organization name |
Case Western Reserve University
|
Department |
Pathology / Systems Biology & Bioinformatics
|
Street address |
2103 Cornell Road
|
City |
Cleveland |
State/province |
Ohio |
ZIP/Postal code |
44120 |
Country |
USA |
|
|
Platforms (1) |
GPL6883 |
Illumina HumanRef-8 v3.0 expression beadchip |
|
Samples (85)
|
|
This SubSeries is part of SuperSeries: |
GSE40006 |
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines |
|
Relations |
BioProject |
PRJNA172175 |
Supplementary file |
Size |
Download |
File type/resource |
GSE39967_RAW.tar |
3.9 Mb |
(http)(custom) |
TAR |
GSE39967_non-normalized_LN.txt.gz |
7.0 Mb |
(ftp)(http) |
TXT |
Processed data included within Sample table |
|
|
|
|
|